This was the stock's second consecutive day of gains.

On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $21.44 which represents a slight increase of $0.66 or 3.18% from the prior close of $20.78. The stock opened at $ and touched ...

Dakota Wealth Management raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 25.6% during the 4th quarter, ...

Atomi Financial Group Inc. grew its holdings in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 28.1% during the fourth ...

As the earnings season unfolds, the prospects of the Consumer Staples sector look mixed. While companies with a strong brand ...

Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a consumer health company worldwide. Valued at $39.8 billion by ...

These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025.

In a report released today, Lauren Lieberman from Barclays maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report), with a price ...

L’Oréal veteran Penelope Giraud will lead the direction of the company’s beauty brands Neutrogena, Aveeno and Dr. Ci Labo in ...

Kenvue isn't growing as quickly as Eli Lilly or Zoetis, but it offers investors a strong starting point for dividend income.

Kenvue Inc. closed 13.37% below its 52-week high of $24.46, which the company achieved on November 26th.

Penelope Giraud will be taking over the role and leading the strategic direction of the Neutrogena, Aveeno and Dr. Ci Labo ...